Genapsys
ClosedTransform the human condition by building a scalable, affordable genomic sequencing ecosystem
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2010
- Business Model
- B2B
- Website
- genapsys.com
- Total Funding
- $205.5M
- Last Round
- $70.0M Series DMay 2021
- Rounds
- 4
About
GenapSys developed a novel electronic DNA sequencing technology for applied genomic testing and medical sequencing. Founded at Stanford, the company built a portable sequencer using electronic detection rather than optical methods. GenapSys raised $249M before filing for Chapter 11 bankruptcy in 2023 and shutting down operations.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biopharmaceutical services company